Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2019 Oct 7;14(10):1493-1499.
doi: 10.2215/CJN.04020419. Epub 2019 Sep 19.

Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors

Affiliations
Comparative Study

Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors

Courtenay M Holscher et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: The risk of hypertension attributable to living kidney donation remains unknown as does the effect of developing postdonation hypertension on subsequent eGFR. We sought to understand the association between living kidney donation, hypertension, and long-term eGFR by comparing donors with a cohort of healthy nondonors.

Design, setting, participants, & measurements: We compared 1295 living kidney donors with median 6 years of follow-up with a weighted cohort of 8233 healthy nondonors. We quantified the risk of self-reported hypertension using a parametric survival model. We examined the association of hypertension with yearly change in eGFR using multilevel linear regression and clustering by participant, with an interaction term for race.

Results: Kidney donation was independently associated with a 19% higher risk of hypertension (adjusted hazard ratio, 1.19; 95% confidence interval, 1.01 to 1.41; P=0.04); this association did not vary by race (interaction P=0.60). For white and black nondonors, there was a mean decline in eGFR (-0.4 and -0.3 ml/min per year, respectively) that steepened after incident hypertension (-0.8 and -0.9 ml/min per year, respectively; both P<0.001). For white and black kidney donors, there was a mean increase in eGFR after donation (+0.4 and +0.6 ml/min per year, respectively) that plateaued after incident hypertension (0 and -0.2 ml/min per year, respectively; P=0.07 and P=0.01, respectively, after hypertension).

Conclusions: Kidney donors are at higher risk of hypertension than similar healthy nondonors, regardless of race. Donors who developed hypertension had a plateau in the usual postdonation increase of eGFR.

Keywords: United States; confidence intervals; follow-up studies; glomerular filtration rate; hypertension; kidney; kidney donation; linear models; living donors; self report; tissue and organ harvesting.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Donors have a higher incidence of hypertension compared to nondonors. Cumulative incidence of self-reported hypertension in black and white kidney donors and weighted nondonors over 15 years.
Figure 2.
Figure 2.
Donors have an increase in eGFR while nondonors have a decrease in eGFR over time. eGFR trajectory in black and white kidney donors and weighted nondonors. Trajectories are shown with 95% confidence intervals (gray).
Figure 3.
Figure 3.
Donors have a plateau in eGFR associated with hypertension while nondonors have a steepened decline in eGFR associated with hypertenion. eGFR trajectory in black and white kidney donors and nondonors after incident hypertension. Trajectories are shown with 95% confidence intervals (gray).

Comment in

References

    1. Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, Segev DL: Risk of end-stage renal disease following live kidney donation. JAMA 311: 579–586, 2014 - PMC - PubMed
    1. Anjum S, Muzaale AD, Massie AB, Bae S, Luo X, Grams ME, Lentine KL, Garg AX, Segev DL: Patterns of end-stage renal disease caused by diabetes, hypertension, and glomerulonephritis in live kidney donors. Am J Transplant 16: 3540–3547, 2016 - PMC - PubMed
    1. Matas AJ, Berglund DM, Vock DM, Ibrahim HN: Causes and timing of end-stage renal disease after living kidney donation. Am J Transplant 18: 1140–1150, 2018 - PubMed
    1. Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EK, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX; Chronic Kidney Disease Prognosis Consortium : Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 374: 411–421, 2016 - PMC - PubMed
    1. Lentine KL, Schnitzler MA, Xiao H, Saab G, Salvalaggio PR, Axelrod D, Davis CL, Abbott KC, Brennan DC: Racial variation in medical outcomes among living kidney donors. N Engl J Med 363: 724–732, 2010 - PMC - PubMed

Publication types